Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Michael Arnold

Concepts (512)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rhabdomyosarcoma
7
2023
52
2.170
 Why?
Sarcoma
6
2024
137
1.530
 Why?
Cancer Survivors
13
2023
203
1.520
 Why?
Wilms Tumor
4
2022
66
1.500
 Why?
Desmoplastic Small Round Cell Tumor
3
2022
3
1.470
 Why?
Sarcoma, Ewing
4
2022
62
1.460
 Why?
Kidney Neoplasms
5
2022
326
1.290
 Why?
Neoplasms, Second Primary
8
2023
91
1.250
 Why?
Biomarkers, Tumor
7
2023
1048
1.230
 Why?
Bone Neoplasms
4
2024
194
1.170
 Why?
Immunohistochemistry
6
2016
1642
1.030
 Why?
Oncogene Proteins, Fusion
7
2022
178
0.990
 Why?
Thyroid Neoplasms
5
2021
262
0.970
 Why?
Rhabdomyosarcoma, Alveolar
3
2021
10
0.870
 Why?
Hirschsprung Disease
5
2023
87
0.800
 Why?
Gene Fusion
3
2020
18
0.800
 Why?
Gastritis
3
2024
84
0.780
 Why?
Myogenic Regulatory Factors
8
2009
47
0.740
 Why?
Child
44
2024
18486
0.720
 Why?
Gallbladder Diseases
1
2019
6
0.670
 Why?
Inclusion Bodies
1
2019
24
0.660
 Why?
Pyridines
3
2022
425
0.650
 Why?
Azabicyclo Compounds
1
2017
5
0.600
 Why?
Niacin
1
2017
19
0.590
 Why?
Neoplasms, Radiation-Induced
5
2021
65
0.590
 Why?
Sarcoma, Synovial
2
2018
10
0.590
 Why?
Helicobacter
1
2016
5
0.560
 Why?
Helicobacter Infections
1
2016
25
0.550
 Why?
Stomach
1
2016
101
0.540
 Why?
Carbodiimides
2
2006
4
0.540
 Why?
Imines
2
2006
7
0.540
 Why?
Child, Preschool
23
2024
9130
0.530
 Why?
Alkaloids
2
2006
22
0.530
 Why?
Breast Neoplasms
6
2023
1872
0.530
 Why?
Rhabdomyosarcoma, Embryonal
3
2022
16
0.530
 Why?
Molecular Diagnostic Techniques
1
2017
91
0.530
 Why?
Biopsy
9
2019
1056
0.520
 Why?
Infant
19
2023
7975
0.520
 Why?
Chromosomal Proteins, Non-Histone
2
2013
99
0.510
 Why?
Adolescent
30
2024
17903
0.500
 Why?
Neoplasms
8
2022
2118
0.500
 Why?
Anti-Bacterial Agents
3
2022
1485
0.490
 Why?
Frozen Sections
1
2015
23
0.490
 Why?
Colestipol
1
2014
1
0.490
 Why?
Humans
77
2024
115611
0.490
 Why?
Ion Exchange Resins
1
2014
5
0.490
 Why?
Allylamine
1
2014
7
0.490
 Why?
Thyroid Diseases
1
2015
30
0.490
 Why?
Pathology, Surgical
1
2014
7
0.490
 Why?
Intestines
2
2015
324
0.490
 Why?
Biopsy, Fine-Needle
1
2015
64
0.480
 Why?
Transcription Factors
6
2017
1528
0.480
 Why?
Thyroid Gland
1
2015
83
0.480
 Why?
Practice Guidelines as Topic
4
2019
1405
0.470
 Why?
Gastrointestinal Agents
1
2014
60
0.470
 Why?
S100 Proteins
1
2014
39
0.460
 Why?
Specimen Handling
1
2014
156
0.440
 Why?
Cerebral Ventricle Neoplasms
1
2013
4
0.440
 Why?
Neoplasms, Neuroepithelial
1
2013
17
0.430
 Why?
Anticholesteremic Agents
1
2014
129
0.420
 Why?
Image Interpretation, Computer-Assisted
1
2014
220
0.420
 Why?
DNA-Binding Proteins
4
2013
1316
0.420
 Why?
Rectum
4
2023
151
0.410
 Why?
Female
49
2024
59931
0.410
 Why?
Young Adult
20
2023
10487
0.400
 Why?
DNA
2
2017
1356
0.380
 Why?
Skin Neoplasms
2
2019
761
0.380
 Why?
Societies, Medical
1
2014
684
0.370
 Why?
Guideline Adherence
1
2014
497
0.360
 Why?
Soft Tissue Neoplasms
2
2024
90
0.360
 Why?
Male
40
2024
55967
0.360
 Why?
Guanidines
2
2006
33
0.340
 Why?
WT1 Proteins
2
2022
12
0.330
 Why?
Predictive Value of Tests
6
2017
1805
0.330
 Why?
Paired Box Transcription Factors
3
2020
37
0.320
 Why?
Risk Assessment
8
2021
2987
0.320
 Why?
Adult
27
2023
30726
0.310
 Why?
Retrospective Studies
15
2024
12608
0.310
 Why?
Risk Factors
14
2023
8699
0.300
 Why?
Gram-Negative Bacteria
2
2018
67
0.300
 Why?
Diagnosis, Differential
5
2020
1357
0.290
 Why?
Bone Development
1
2007
48
0.280
 Why?
Pediatrics
1
2014
986
0.280
 Why?
Colon
3
2019
234
0.280
 Why?
Pyrimidines
2
2006
376
0.270
 Why?
Intestinal Mucosa
4
2019
528
0.270
 Why?
Bone and Bones
2
2018
283
0.260
 Why?
Antineoplastic Agents
4
2022
1893
0.260
 Why?
Vinyl Compounds
1
2005
5
0.250
 Why?
Guanidine
1
2005
18
0.250
 Why?
Cartilage
1
2007
182
0.250
 Why?
Survivors
2
2019
404
0.250
 Why?
Radiotherapy
3
2021
177
0.250
 Why?
Genetic Predisposition to Disease
4
2020
2127
0.240
 Why?
Infant, Newborn
10
2022
5059
0.240
 Why?
Carcinoma, Renal Cell
2
2020
168
0.240
 Why?
Chondrocytes
1
2007
199
0.240
 Why?
Eosinophilia
2
2024
187
0.240
 Why?
Mutation
5
2021
3364
0.240
 Why?
Pathology
1
2024
21
0.230
 Why?
Duodenitis
1
2024
7
0.230
 Why?
Polyketides
1
2023
3
0.230
 Why?
Education, Distance
1
2024
39
0.220
 Why?
Dysautonomia, Familial
1
2023
2
0.220
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2018
1361
0.220
 Why?
Disease-Free Survival
4
2020
621
0.220
 Why?
Microbial Sensitivity Tests
3
2022
299
0.220
 Why?
Orbital Neoplasms
1
2023
21
0.220
 Why?
SMARCB1 Protein
2
2013
16
0.220
 Why?
Prognosis
7
2023
3339
0.210
 Why?
Eyelids
1
2023
29
0.210
 Why?
Retinal Degeneration
1
2023
30
0.210
 Why?
Mice
17
2023
15052
0.210
 Why?
Enterocolitis
1
2023
33
0.210
 Why?
Telomere Homeostasis
2
2020
24
0.200
 Why?
Ribonucleotide Reductases
1
2022
21
0.200
 Why?
Bone Marrow
1
2023
249
0.200
 Why?
Xenograft Model Antitumor Assays
4
2019
704
0.200
 Why?
Norwood Procedures
1
2022
23
0.200
 Why?
Age Factors
4
2019
2907
0.200
 Why?
Radiation Dosage
2
2019
139
0.200
 Why?
Muscle Proteins
3
2017
209
0.200
 Why?
Vulvar Neoplasms
1
2021
10
0.200
 Why?
Telomere Shortening
1
2021
18
0.200
 Why?
Incidence
7
2022
2335
0.200
 Why?
MEF2 Transcription Factors
8
2009
53
0.200
 Why?
Appendix
1
2021
26
0.190
 Why?
Radiation
1
2021
24
0.190
 Why?
Alphapapillomavirus
1
2021
36
0.190
 Why?
Neurodegenerative Diseases
1
2023
92
0.190
 Why?
MyoD Protein
2
2021
26
0.190
 Why?
Histone Deacetylases
3
2007
196
0.190
 Why?
Gonorrhea
1
2022
54
0.190
 Why?
Middle Aged
15
2021
27014
0.190
 Why?
Biliary Tract Neoplasms
1
2021
20
0.190
 Why?
Kaplan-Meier Estimate
3
2023
815
0.190
 Why?
Hypoplastic Left Heart Syndrome
1
2022
113
0.190
 Why?
Drug Resistance, Bacterial
1
2022
156
0.190
 Why?
Forkhead Box Protein O1
1
2020
14
0.190
 Why?
Colonic Neoplasms
2
2013
222
0.180
 Why?
Schwann Cells
1
2020
27
0.180
 Why?
Neoplasm Recurrence, Local
3
2023
863
0.180
 Why?
Colitis
2
2021
226
0.180
 Why?
Chromosome Breakpoints
1
2020
6
0.180
 Why?
Rhabdomyoma
1
2020
10
0.180
 Why?
Drug Evaluation, Preclinical
2
2018
166
0.180
 Why?
Chromosomes, Human, Pair 19
1
2020
22
0.180
 Why?
Nanoparticles
2
2015
316
0.180
 Why?
Protein-Tyrosine Kinases
1
2023
396
0.180
 Why?
Colitis, Ischemic
1
2019
6
0.180
 Why?
Diagnostic Errors
3
2017
151
0.170
 Why?
Reproducibility of Results
3
2021
2800
0.170
 Why?
Phenotype
5
2015
2831
0.170
 Why?
Ventricular Outflow Obstruction
1
2020
37
0.170
 Why?
Polymorphism, Single Nucleotide
4
2021
1918
0.170
 Why?
Structure-Activity Relationship
2
2018
511
0.170
 Why?
Heart Neoplasms
1
2020
50
0.170
 Why?
Neurogenesis
1
2020
102
0.170
 Why?
Appendiceal Neoplasms
1
2019
14
0.170
 Why?
Colitis, Ulcerative
1
2021
105
0.170
 Why?
Neural Stem Cells
1
2020
115
0.170
 Why?
Carcinoid Tumor
1
2019
25
0.170
 Why?
Tumor Suppressor Protein p53
2
2020
449
0.170
 Why?
Gallbladder
1
2019
14
0.170
 Why?
Neurofibromatosis 1
1
2019
36
0.170
 Why?
Research Report
1
2019
76
0.160
 Why?
Vagina
1
2021
148
0.160
 Why?
Neoplasms, Germ Cell and Embryonal
1
2020
60
0.160
 Why?
Prospective Studies
5
2021
6264
0.160
 Why?
Receptor, Serotonin, 5-HT2A
1
2019
19
0.160
 Why?
Cholecystectomy
1
2019
45
0.160
 Why?
Enteric Nervous System
1
2019
26
0.160
 Why?
Telomere-Binding Proteins
1
2020
88
0.160
 Why?
Gene Rearrangement
2
2022
135
0.160
 Why?
Glucose Transporter Type 1
1
2018
42
0.160
 Why?
Radiation Injuries
1
2019
127
0.160
 Why?
Anal Canal
1
2019
83
0.160
 Why?
Ohio
2
2017
136
0.160
 Why?
Digestive System Surgical Procedures
1
2019
89
0.150
 Why?
Topoisomerase II Inhibitors
1
2018
23
0.150
 Why?
Gene Expression Regulation, Neoplastic
2
2021
1147
0.150
 Why?
Age of Onset
1
2019
450
0.150
 Why?
DNA Topoisomerases, Type II
1
2018
45
0.150
 Why?
Glioma
1
2021
296
0.150
 Why?
Sequence Analysis, RNA
1
2020
390
0.150
 Why?
Epithelium
1
2019
297
0.150
 Why?
Drug Resistance, Multiple, Bacterial
1
2018
62
0.150
 Why?
Carcinoma, Basal Cell
1
2019
68
0.150
 Why?
Escherichia coli
2
2022
730
0.150
 Why?
Curriculum
1
2024
853
0.150
 Why?
Eosinophilic Esophagitis
1
2022
295
0.150
 Why?
Antineoplastic Agents, Immunological
1
2019
154
0.150
 Why?
Animals
17
2023
32102
0.150
 Why?
Half-Life
1
2017
145
0.150
 Why?
Gram-Negative Bacterial Infections
1
2017
37
0.150
 Why?
Interleukin-8
1
2018
241
0.150
 Why?
Povidone
1
2017
5
0.150
 Why?
Nephroma, Mesoblastic
1
2017
3
0.140
 Why?
Immunocompromised Host
1
2019
197
0.140
 Why?
Chemoradiotherapy
2
2019
187
0.140
 Why?
Drug Discovery
1
2018
124
0.140
 Why?
Nuclear Receptor Coactivator 1
1
2017
10
0.140
 Why?
Computer Communication Networks
1
2017
32
0.140
 Why?
Oncogene Protein p21(ras)
1
2017
16
0.140
 Why?
Excipients
1
2017
49
0.140
 Why?
Cohort Studies
6
2023
4945
0.140
 Why?
Pathology, Clinical
1
2017
32
0.140
 Why?
Inflammatory Bowel Diseases
1
2021
289
0.140
 Why?
Candidiasis
1
2017
58
0.140
 Why?
Cellulose
1
2017
61
0.140
 Why?
Esophagitis
1
2017
65
0.130
 Why?
Oncolytic Viruses
1
2015
5
0.130
 Why?
Heart Transplantation
1
2022
671
0.130
 Why?
Oncolytic Virotherapy
1
2015
8
0.130
 Why?
Enterocolitis, Neutropenic
1
2015
5
0.130
 Why?
Liver Neoplasms
1
2020
521
0.130
 Why?
Survival Rate
4
2023
1650
0.130
 Why?
Stereoisomerism
2
2006
91
0.130
 Why?
beta 2-Microglobulin
1
2015
45
0.130
 Why?
Virus Internalization
1
2015
41
0.130
 Why?
Cardiac Surgical Procedures
1
2020
413
0.130
 Why?
Clinical Trials as Topic
2
2020
941
0.130
 Why?
Receptors, Virus
1
2015
75
0.130
 Why?
Immunotherapy
2
2018
479
0.130
 Why?
Sarcoma, Experimental
1
2015
5
0.130
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2015
930
0.130
 Why?
Antibodies, Monoclonal, Humanized
1
2019
667
0.120
 Why?
Granuloma, Plasma Cell
1
2015
11
0.120
 Why?
Granuloma, Foreign-Body
1
2015
10
0.120
 Why?
Colesevelam Hydrochloride
1
2014
7
0.120
 Why?
Cholestyramine Resin
1
2014
7
0.120
 Why?
Information Dissemination
1
2017
193
0.120
 Why?
Gastrointestinal Tract
1
2017
168
0.120
 Why?
Thyroidectomy
1
2015
52
0.120
 Why?
Herpesvirus 1, Human
1
2015
78
0.120
 Why?
Neuroblastoma
1
2015
130
0.120
 Why?
In Situ Hybridization, Fluorescence
1
2016
310
0.120
 Why?
Desmin
1
2014
30
0.120
 Why?
Albumins
1
2015
91
0.120
 Why?
Interleukin-6
1
2018
677
0.120
 Why?
Social Media
1
2017
135
0.120
 Why?
Quality Control
1
2014
147
0.120
 Why?
Histocompatibility Antigens Class I
1
2015
174
0.120
 Why?
Gastrointestinal Neoplasms
1
2015
59
0.120
 Why?
Muscle, Skeletal
4
2007
1447
0.120
 Why?
Cerebral Ventricles
1
2014
47
0.120
 Why?
Tubulin
1
2015
123
0.120
 Why?
Paclitaxel
1
2015
192
0.110
 Why?
Keratins
1
2014
176
0.110
 Why?
MicroRNAs
1
2020
607
0.110
 Why?
Cost-Benefit Analysis
1
2016
548
0.110
 Why?
Subarachnoid Hemorrhage
1
2014
60
0.110
 Why?
Treatment Outcome
5
2022
9159
0.110
 Why?
Vascular Malformations
1
2014
47
0.110
 Why?
Microscopy
1
2014
125
0.110
 Why?
Ganglioneuroma
1
2013
2
0.110
 Why?
Cerebral Hemorrhage
1
2014
96
0.110
 Why?
Ileal Neoplasms
1
2013
4
0.110
 Why?
Glucose-6-Phosphatase
1
2013
31
0.110
 Why?
Hypertrophy
2
2018
110
0.110
 Why?
Food
1
2015
160
0.110
 Why?
Repressor Proteins
2
2006
369
0.110
 Why?
Follow-Up Studies
5
2019
4440
0.110
 Why?
Lateral Ventricles
1
2013
23
0.110
 Why?
Calcium Phosphates
1
2013
25
0.110
 Why?
Human Growth Hormone
1
2013
38
0.110
 Why?
United States
7
2019
12297
0.110
 Why?
Cell Line, Tumor
5
2019
2751
0.110
 Why?
Gastrointestinal Diseases
1
2015
184
0.110
 Why?
Microscopy, Electron, Transmission
1
2013
138
0.110
 Why?
Neoplasms, Multiple Primary
1
2013
52
0.110
 Why?
Multiplex Polymerase Chain Reaction
1
2013
45
0.100
 Why?
Neutropenia
1
2013
127
0.100
 Why?
COS Cells
3
2007
175
0.100
 Why?
Proportional Hazards Models
3
2020
1087
0.100
 Why?
Sepsis
1
2018
515
0.100
 Why?
Enteritis
2
2024
82
0.100
 Why?
Endocytosis
1
2013
152
0.100
 Why?
Patient Selection
1
2015
654
0.100
 Why?
Colonic Polyps
1
2013
67
0.100
 Why?
Rhabdoid Tumor
1
2012
79
0.100
 Why?
Brain Neoplasms
1
2019
980
0.100
 Why?
Feasibility Studies
1
2014
741
0.100
 Why?
Spinal Cord
1
2014
351
0.100
 Why?
Neurosurgical Procedures
1
2013
157
0.100
 Why?
Adenoma
1
2013
187
0.090
 Why?
Recurrence
3
2024
952
0.090
 Why?
Colonoscopy
1
2013
204
0.090
 Why?
RNA, Small Interfering
1
2013
544
0.090
 Why?
Constipation
2
2023
75
0.090
 Why?
Sarcomeres
2
2007
89
0.090
 Why?
Combined Modality Therapy
1
2013
1127
0.090
 Why?
SEER Program
2
2021
195
0.090
 Why?
Leukemia, Myelomonocytic, Acute
1
2009
7
0.090
 Why?
Longitudinal Studies
3
2021
2420
0.080
 Why?
Aged
6
2019
19255
0.080
 Why?
Muscle Fibers, Skeletal
2
2007
169
0.080
 Why?
Myeloid-Lymphoid Leukemia Protein
1
2009
63
0.080
 Why?
Coccidioidomycosis
1
2008
7
0.080
 Why?
Sensitivity and Specificity
1
2012
1718
0.080
 Why?
Cell Proliferation
3
2018
2194
0.080
 Why?
Proto-Oncogene Proteins c-jun
1
2008
47
0.080
 Why?
Polyethylene Glycols
1
2013
576
0.080
 Why?
Risk
2
2021
819
0.070
 Why?
Doxorubicin
2
2023
290
0.070
 Why?
Waste Disposal, Fluid
1
2008
45
0.070
 Why?
Gene Expression Regulation, Developmental
3
2007
794
0.070
 Why?
Case-Control Studies
3
2021
3023
0.070
 Why?
Canada
2
2019
335
0.070
 Why?
Mice, Transgenic
3
2007
1970
0.070
 Why?
Dwarfism
1
2007
15
0.070
 Why?
Pressure
1
2008
220
0.070
 Why?
Myeloid Cells
1
2008
127
0.070
 Why?
Gastroschisis
1
2006
14
0.070
 Why?
Colectomy
2
2019
87
0.070
 Why?
Tumor Microenvironment
2
2019
431
0.070
 Why?
Actinin
1
2006
13
0.070
 Why?
Myopathies, Structural, Congenital
1
2005
6
0.070
 Why?
Cell Differentiation
3
2008
1700
0.070
 Why?
Neoplastic Stem Cells
1
2009
331
0.060
 Why?
Lung Neoplasms
1
2018
2207
0.060
 Why?
Neovascularization, Physiologic
1
2007
174
0.060
 Why?
Alkylation
1
2005
19
0.060
 Why?
Promoter Regions, Genetic
2
2006
1122
0.060
 Why?
Neoplasm Staging
2
2020
1178
0.060
 Why?
Aged, 80 and over
4
2017
6419
0.060
 Why?
Osteogenesis
1
2007
184
0.060
 Why?
Molecular Sequence Data
5
2007
2790
0.060
 Why?
Oligonucleotide Array Sequence Analysis
3
2015
746
0.060
 Why?
Base Sequence
4
2013
2114
0.060
 Why?
Time Factors
3
2019
6165
0.060
 Why?
Molecular Medicine
1
2024
2
0.060
 Why?
Myocytes, Smooth Muscle
1
2006
239
0.060
 Why?
Daunorubicin
1
2023
24
0.060
 Why?
Podophyllotoxin
1
2023
7
0.060
 Why?
Anthracyclines
1
2023
41
0.060
 Why?
Public Opinion
1
2024
59
0.060
 Why?
Kinetin
1
2023
1
0.050
 Why?
Gait Ataxia
1
2023
5
0.050
 Why?
T-Lymphocytes
2
2021
1756
0.050
 Why?
Real-Time Polymerase Chain Reaction
2
2015
317
0.050
 Why?
Breast
1
2023
138
0.050
 Why?
Necrosis
1
2023
210
0.050
 Why?
Placenta
1
2008
624
0.050
 Why?
Deoxyadenine Nucleotides
1
2022
13
0.050
 Why?
Neisseria gonorrhoeae
1
2022
20
0.050
 Why?
Educational Measurement
1
2024
262
0.050
 Why?
Allosteric Regulation
1
2022
84
0.050
 Why?
Endoscopy, Gastrointestinal
1
2024
202
0.050
 Why?
Carrier Proteins
1
2006
701
0.050
 Why?
Mice, SCID
2
2015
321
0.050
 Why?
Gene Ontology
1
2021
47
0.050
 Why?
Receptor Protein-Tyrosine Kinases
1
2023
225
0.050
 Why?
Haploinsufficiency
1
2021
44
0.050
 Why?
Colon, Sigmoid
1
2021
15
0.050
 Why?
Papillomaviridae
1
2021
100
0.050
 Why?
Drug Screening Assays, Antitumor
1
2021
180
0.050
 Why?
CTLA-4 Antigen
1
2021
78
0.050
 Why?
Gynecologic Surgical Procedures
1
2021
49
0.050
 Why?
Neoplasm Grading
1
2021
244
0.050
 Why?
DNA Copy Number Variations
1
2021
156
0.050
 Why?
Administration, Oral
1
2023
734
0.050
 Why?
Myocardium
1
2006
926
0.050
 Why?
Cloaca
1
2021
48
0.040
 Why?
Gene Expression Regulation
2
2007
2353
0.040
 Why?
Radiotherapy, Adjuvant
1
2021
182
0.040
 Why?
Neoplasm, Residual
1
2021
105
0.040
 Why?
Transcription Initiation Site
1
2020
40
0.040
 Why?
Constriction, Pathologic
1
2021
210
0.040
 Why?
Mice, Knockout
4
2007
2604
0.040
 Why?
Genomic Instability
1
2020
38
0.040
 Why?
Genes, ras
1
2020
91
0.040
 Why?
Eosinophils
1
2022
282
0.040
 Why?
Students, Medical
1
2024
277
0.040
 Why?
Homeodomain Proteins
1
2023
465
0.040
 Why?
Hepatocyte Growth Factor
1
2019
33
0.040
 Why?
Tissue Donors
1
2022
331
0.040
 Why?
Dose-Response Relationship, Radiation
1
2019
130
0.040
 Why?
Internet
1
2024
602
0.040
 Why?
Aneuploidy
1
2020
86
0.040
 Why?
Radiotherapy Dosage
1
2019
246
0.040
 Why?
Tumor Burden
1
2020
261
0.040
 Why?
Proto-Oncogene Proteins c-met
1
2019
67
0.040
 Why?
Cell- and Tissue-Based Therapy
1
2019
57
0.040
 Why?
Mice, Inbred BALB C
1
2022
1168
0.040
 Why?
Introns
1
2020
226
0.040
 Why?
Anorectal Malformations
1
2020
104
0.040
 Why?
Cell Transformation, Neoplastic
2
2013
314
0.040
 Why?
Receptors, Interleukin-8A
1
2018
5
0.040
 Why?
Cytokine Receptor gp130
1
2018
10
0.040
 Why?
North America
1
2019
261
0.040
 Why?
Diarrhea
1
2019
173
0.040
 Why?
Early Diagnosis
1
2019
220
0.040
 Why?
Abdominal Pain
1
2019
135
0.040
 Why?
Gene Frequency
1
2020
485
0.040
 Why?
Hydrazines
1
2018
28
0.040
 Why?
Linkage Disequilibrium
1
2019
247
0.040
 Why?
Appendicitis
1
2019
108
0.040
 Why?
Quinoxalines
1
2018
61
0.040
 Why?
Primary Cell Culture
1
2018
149
0.040
 Why?
Osteosarcoma
1
2018
66
0.040
 Why?
T-Lymphocytes, Cytotoxic
1
2018
156
0.040
 Why?
Immunotherapy, Adoptive
1
2019
194
0.040
 Why?
Lymphocytes, Tumor-Infiltrating
1
2018
111
0.040
 Why?
Genetic Loci
1
2019
264
0.040
 Why?
Immunophenotyping
1
2018
277
0.040
 Why?
Mice, Mutant Strains
2
2008
271
0.040
 Why?
DNA Methylation
1
2021
498
0.040
 Why?
Computer Simulation
1
2021
881
0.040
 Why?
Leukocytes
1
2018
281
0.040
 Why?
HLA Antigens
1
2018
223
0.040
 Why?
Up-Regulation
1
2020
820
0.040
 Why?
Disease Management
1
2021
563
0.040
 Why?
Ventricular Function, Left
1
2020
467
0.030
 Why?
Molecular Structure
1
2018
447
0.030
 Why?
Staining and Labeling
1
2017
139
0.030
 Why?
Recovery of Function
1
2020
577
0.030
 Why?
Medical Informatics
1
2017
93
0.030
 Why?
Embryo, Mammalian
2
2007
214
0.030
 Why?
Transcriptome
1
2021
736
0.030
 Why?
Palliative Care
1
2022
642
0.030
 Why?
Biomarkers
2
2022
3467
0.030
 Why?
Tissue Array Analysis
1
2015
49
0.030
 Why?
Models, Statistical
1
2019
606
0.030
 Why?
Nephrectomy
1
2017
150
0.030
 Why?
Osteonectin
1
2015
2
0.030
 Why?
Tomography, X-Ray Computed
2
2015
2392
0.030
 Why?
Dose-Response Relationship, Drug
1
2019
1870
0.030
 Why?
Caveolin 1
1
2015
21
0.030
 Why?
Gene Expression Regulation, Enzymologic
2
2007
274
0.030
 Why?
Protein Conformation
1
2018
822
0.030
 Why?
Neoplasm Metastasis
1
2017
526
0.030
 Why?
Signal Transduction
3
2019
4541
0.030
 Why?
Sulfonamides
1
2018
447
0.030
 Why?
Genetic Variation
1
2020
880
0.030
 Why?
Immunoenzyme Techniques
1
2015
193
0.030
 Why?
Skin
1
2019
662
0.030
 Why?
Tissue Distribution
1
2015
324
0.030
 Why?
Cerebral Infarction
1
2014
39
0.030
 Why?
Mice, Nude
1
2015
639
0.030
 Why?
Thoracic Vertebrae
1
2014
71
0.030
 Why?
Dwarfism, Pituitary
1
2013
3
0.030
 Why?
Multiple Endocrine Neoplasia Type 2b
1
2013
6
0.030
 Why?
Fatal Outcome
1
2014
286
0.030
 Why?
Tumor Cells, Cultured
1
2015
850
0.030
 Why?
Models, Molecular
1
2018
1390
0.030
 Why?
Disease Progression
1
2020
2418
0.030
 Why?
Anastomosis, Surgical
1
2013
140
0.030
 Why?
Genome-Wide Association Study
1
2019
1217
0.030
 Why?
Hyperplasia
1
2013
166
0.030
 Why?
Disease Models, Animal
1
2022
3580
0.030
 Why?
Microscopy, Electron
1
2013
409
0.030
 Why?
Cells, Cultured
2
2013
3914
0.030
 Why?
Lumbar Vertebrae
1
2014
217
0.030
 Why?
Postoperative Complications
1
2023
2161
0.030
 Why?
DNA Mutational Analysis
1
2013
372
0.030
 Why?
Flow Cytometry
1
2015
1083
0.030
 Why?
Microscopy, Confocal
1
2013
299
0.020
 Why?
DNA Primers
1
2013
514
0.020
 Why?
Amino Acid Sequence
2
2006
2000
0.020
 Why?
Inflammation
1
2022
2499
0.020
 Why?
Cell Line
2
2007
2651
0.020
 Why?
Drug Resistance, Neoplasm
1
2015
638
0.020
 Why?
Protein Binding
2
2007
1917
0.020
 Why?
Gene Expression Profiling
2
2009
1536
0.020
 Why?
Heart Arrest
1
2014
289
0.020
 Why?
Reactive Oxygen Species
1
2013
549
0.020
 Why?
Surveys and Questionnaires
1
2021
4668
0.020
 Why?
Leukemia Virus, Murine
1
2009
16
0.020
 Why?
Colony-Forming Units Assay
1
2009
90
0.020
 Why?
Interferon Regulatory Factors
1
2009
29
0.020
 Why?
Gene Expression Regulation, Leukemic
1
2009
49
0.020
 Why?
Transduction, Genetic
1
2009
114
0.020
 Why?
Bone Marrow Transplantation
1
2009
239
0.020
 Why?
Granulocytes
1
2008
78
0.020
 Why?
Mice, Inbred C57BL
2
2009
4773
0.020
 Why?
Water Movements
1
2008
22
0.020
 Why?
Neoplasm Invasiveness
1
2009
445
0.020
 Why?
Sewage
1
2008
27
0.020
 Why?
Leupeptins
1
2007
10
0.020
 Why?
Connectin
1
2007
30
0.020
 Why?
RNA, Messenger
1
2015
2574
0.020
 Why?
Mice, Inbred NOD
1
2009
560
0.020
 Why?
Morbidity
1
2008
278
0.020
 Why?
Ubiquitin
1
2007
64
0.020
 Why?
Proteasome Endopeptidase Complex
1
2007
136
0.020
 Why?
Hematopoiesis
1
2008
173
0.020
 Why?
Bone Marrow Cells
1
2008
268
0.020
 Why?
Mice, Inbred ICR
1
2006
111
0.020
 Why?
Isoenzymes
1
2007
285
0.020
 Why?
Feedback, Physiological
1
2006
73
0.020
 Why?
Protein Methyltransferases
1
2006
2
0.020
 Why?
Neoplasm Proteins
1
2009
385
0.020
 Why?
Gene Deletion
1
2007
355
0.020
 Why?
Veins
1
2006
57
0.020
 Why?
Lung
1
2018
3673
0.020
 Why?
Animals, Newborn
1
2007
780
0.020
 Why?
Monocytes
1
2008
507
0.020
 Why?
Cell Movement
1
2009
867
0.020
 Why?
Down-Regulation
1
2007
601
0.020
 Why?
Histone-Lysine N-Methyltransferase
1
2006
96
0.020
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2006
225
0.020
 Why?
Enhancer Elements, Genetic
1
2005
150
0.010
 Why?
Pregnancy Complications, Infectious
1
2008
289
0.010
 Why?
Oxidation-Reduction
1
2007
924
0.010
 Why?
Arteries
1
2006
250
0.010
 Why?
Protein Structure, Tertiary
1
2006
804
0.010
 Why?
Intracellular Signaling Peptides and Proteins
1
2006
388
0.010
 Why?
Magnetic Resonance Imaging
1
2014
3071
0.010
 Why?
Gene Expression
1
2006
1436
0.010
 Why?
Transcription, Genetic
1
2005
1310
0.010
 Why?
Pregnancy
1
2008
5550
0.010
 Why?
Arnold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (512) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)